BioPharm International Tech Forum “Overcoming Challenges on the Road to Commercialization
Cell therapies and gene therapies continue to challenge the development and manufacturing capabilities of biopharma companies and contract manufacturers. These therapies and personalized medicines, however, require analytical methods, supply chains, manufacturing processes, and regulatory standards that may be different from more traditional biologic drug development and manufacturing.
This Technology Forum will explore the current state of commercialization for cell and gene therapies and the patient and physician perspective, as well as the need for technologies, processes, and strategies to ensure competent delivery of these treatments to patients.
Speakers: Emily Moran and Eileen Brett, Cell & Gene Therapy Development and Manufacturing, The Discovery Labs